{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:16:27Z","timestamp":1790622987523,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Nonvalvular atrial fibrillation (NVAF) concomitant with coronary artery disease (CAD) may increase the risk of thromboembolism. Antithrombotic therapy for NVAF patients with percutaneous coronary intervention (PCI) remains contradictory and challenging. This study aimed to assess the safety and efficacy of left atrial appendage closure (LAAC) in a cohort of patients with NVAF and PCI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 109 patients undergoing LAAC procedures between March 2017 and December 2020 were categorized into 2 groups, Group I included 36 patients with PCI while group II included 73 patients without. Peri-procedural and long-term complications, as well as ischemia and bleeding events, were retrospectively analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Group I had more diabetes mellitus (55.6% vs. 26.0%; p\u2009=\u20090.003), higher CHA2DS2-VASc scores (5.44\u2009\u00b1\u20091.85 vs. 4.22\u2009\u00b1\u20091.64; p\u2009=\u20090.002) and HAS-BLED scores (3.39\u2009\u00b1\u20090.93 vs. 2.74\u2009\u00b1\u20091.05; p\u2009=\u20090.003) compared to Group II. Procedure-related complications within 7 days were similar in both groups (8.3% vs. 8.2%; P\u2009=\u20091.000). Over a median follow-up period of 20.9 months, there were no significant differences between two subgroups with regard to cardiovascular death (2.8% vs. 0%, p\u2009=\u20090.330), stroke\/transient ischemic attack (2.8% vs. 5.5%, p\u2009=\u20091.000), major bleeding (0% vs. 2.7%, p\u2009=\u20091.000) and device-related thrombus (8.3% vs. 1.4%, p\u2009=\u20090.104). The observed annualized thromboembolic and major bleeding events determined by Kaplan\u2013Meier analysis decreased by 82.4% and 100% in group I, 55.9% and 75.8% in group II, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>LAAC is a safe and effective option for stroke prevention in NVAF patients with PCI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02865-6","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T18:44:02Z","timestamp":1664822642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention"],"prefix":"10.1186","volume":"22","author":[{"given":"Yunan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"9989","key":"2865_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154\u201362.","journal-title":"Lancet"},{"issue":"4","key":"2865_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/joa3.12073","volume":"34","author":"YH Kim","year":"2018","unstructured":"Kim YH, Shim J, Tsai CT, Wang CC, Vilela G, Muengtaweepongsa S, Kurniawan M, Maskon O, Li Fern H, Nguyen TH, et al. XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia. J Arrhythm. 2018;34(4):418\u201327.","journal-title":"J Arrhythm"},{"key":"2865_CR3","doi-asserted-by":"crossref","unstructured":"Martinez BK, Sood NA, Bunz TJ, Coleman CI. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation. J Am Heart Assoc 2018, 7(8).","DOI":"10.1161\/JAHA.118.008643"},{"issue":"3","key":"2865_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.114.013267","volume":"132","author":"M Sharma","year":"2015","unstructured":"Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. Circulation. 2015;132(3):194\u2013204.","journal-title":"Circulation"},{"issue":"3","key":"2865_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jacc.2016.10.010","volume":"69","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Gibson DN, Kar S, O\u2019Neill W, Doshi SK, Horton RP, Buchbinder M, Gordon NT, Holmes DR. Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. J Am Coll Cardiol. 2017;69(3):253\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"3\u20134","key":"2865_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jjcc.2012.12.002","volume":"61","author":"M Akao","year":"2013","unstructured":"Akao M, Chun YH, Wada H, Esato M, Hashimoto T, Abe M, Hasegawa K, Tsuji H, Furuke K, Fushimi AFRI. Current status of clinical background of patients with atrial fibrillation in a community-based survey: The Fushimi AF Registry. J Cardiol. 2013;61(3\u20134):260\u20136.","journal-title":"J Cardiol"},{"issue":"8","key":"2865_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/imj.12487","volume":"44","author":"H Zhang","year":"2014","unstructured":"Zhang H, Yang Y, Zhu J, Shao X, Liu Y, Zhao L, Yu P, Zhang H, He Q, Gu X. Baseline characteristics and management of patients with atrial fibrillation\/flutter in the emergency department: results of a prospective, multicentre registry in China. Intern Med J. 2014;44(8):742\u20138.","journal-title":"Intern Med J"},{"key":"2865_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","volume":"6","author":"M Zoni-Berisso","year":"2014","unstructured":"Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213\u201320.","journal-title":"Clin Epidemiol"},{"issue":"9","key":"2865_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4244\/EIJV8I9A163","volume":"8","author":"T Pilgrim","year":"2013","unstructured":"Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, et al. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents. EuroIntervention: J EuroPCR Collab Working Group Interventional Cardiol Eur Soc Cardiol. 2013;8(9):1061\u201371.","journal-title":"EuroIntervention: J EuroPCR Collab Working Group Interventional Cardiol Eur Soc Cardiol"},{"key":"2865_CR10","doi-asserted-by":"crossref","unstructured":"Fastner C, Brachmann J, Lewalter T, Zeymer U, Sievert H, Borggrefe M, Nienaber CA, Wei\u00df C, Pleger ST, Ince H, et al: Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry. Clinical research in cardiology: official journal of the German Cardiac Society 2020.","DOI":"10.1007\/s00392-020-01638-5"},{"issue":"11","key":"2865_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00392-020-01627-8","volume":"109","author":"C Fastner","year":"2020","unstructured":"Fastner C, Brachmann J, Lewalter T, Zeymer U, Sievert H, Borggrefe M, Wei\u00df C, Geist V, Krapivsky A, K\u00e4unicke M, et al. Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicenter German LAARGE registry. Clin Res cardiology: official J German Cardiac Soc. 2020;109(11):1333\u201341.","journal-title":"Clin Res cardiology: official J German Cardiac Soc"},{"key":"2865_CR12","doi-asserted-by":"publisher","first-page":"6704031","DOI":"10.1155\/2019\/6704031","volume":"2019","author":"P Merella","year":"2019","unstructured":"Merella P, Lorenzoni G, Delitala AP, Sechi F, Decandia F, Viola G, Berne P, Deiana G, Mazzone P, Casu G. Left Atrial Appendage Occlusion in High Bleeding Risk Patients. J Interv Cardiol. 2019;2019:6704031.","journal-title":"J Interv Cardiol"},{"issue":"10","key":"2865_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/europace\/euu174","volume":"16","author":"B Meier","year":"2014","unstructured":"Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C, Glikson M, Document R. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace. 2014;16(10):1397\u2013416.","journal-title":"Europace"},{"issue":"12","key":"2865_CR14","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","volume":"33","author":"L Friberg","year":"2012","unstructured":"Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500\u201310.","journal-title":"Eur Heart J"},{"issue":"2","key":"2865_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"GY Lip","year":"2011","unstructured":"Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011;57(2):173\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2865_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","volume":"129","author":"M Lamberts","year":"2014","unstructured":"Lamberts M, Gislason GH, Lip GY, Lassen JF, Olesen JB, Mikkelsen AP, S\u00f8rensen R, K\u00f8ber L, Torp-Pedersen C, Hansen ML. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation. 2014;129(15):1577\u201385.","journal-title":"Circulation"},{"issue":"10","key":"2865_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","volume":"126","author":"M Lamberts","year":"2012","unstructured":"Lamberts M, Olesen JB, Ruwald MH, Hansen CM, Karasoy D, Kristensen SL, K\u00f8ber L, Torp-Pedersen C, Gislason GH, Hansen ML. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation. 2012;126(10):1185\u201393.","journal-title":"Circulation"},{"issue":"13","key":"2865_CR18","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","volume":"75","author":"JV Freeman","year":"2020","unstructured":"Freeman JV, Varosy P, Price MJ, Slotwiner D, Kusumoto FM, Rammohan C, Kavinsky CJ, Turi ZG, Akar J, Koutras C, et al. The NCDR Left Atrial Appendage Occlusion Registry. J Am Coll Cardiol. 2020;75(13):1503\u201318.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2865_CR19","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.4244\/EIJ-D-19-00128","volume":"15","author":"A Cresti","year":"2019","unstructured":"Cresti A, Garc\u00eda-Fern\u00e1ndez MA, Sievert H, Mazzone P, Baratta P, Solari M, Geyer A, De Sensi F, Limbruno U. Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. EuroIntervention: J EuroPCR Collab Working Group Interventional Cardiol Eur Soc Cardiol. 2019;15(3):e225\u201330.","journal-title":"EuroIntervention: J EuroPCR Collab Working Group Interventional Cardiol Eur Soc Cardiol"},{"issue":"9","key":"2865_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, Doshi SK, Swarup V, Gibson DN, Maini B, Gordon NT, Main ML, Reddy VY. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes. Circulation. 2018;138(9):874\u201385.","journal-title":"Circulation"},{"issue":"14","key":"2865_CR21","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F, Lepillier A, Pierre B, Abbey S, Fatemi M, Franceschi F, Guedeney P, Jacon P, et al. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. J Am Coll Cardiol. 2018;71(14):1528\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"2865_CR22","doi-asserted-by":"crossref","unstructured":"Yu J, Bai Y, Jiang LS: Device related thrombus after left atrial appendage closure: State of the art. Pacing and clinical electrophysiology: PACE 2020.","DOI":"10.1111\/pace.14122"},{"issue":"4","key":"2865_CR23","doi-asserted-by":"publisher","first-page":"e006841","DOI":"10.1161\/CIRCEP.118.006841","volume":"12","author":"LV Boersma","year":"2019","unstructured":"Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, Gori T, Meincke F, Protopopov AV, Betts T, et al. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage. Circulation Arrhythmia and electrophysiology. 2019;12(4):e006841.","journal-title":"Circulation Arrhythmia and electrophysiology"},{"issue":"17","key":"2865_CR24","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1161\/CIRCULATIONAHA.119.040860","volume":"140","author":"L Asmarats","year":"2019","unstructured":"Asmarats L, Cruz-Gonz\u00e1lez I, Nombela-Franco L, Arzamendi D, Peral V, Nietlispach F, Latib A, Maffeo D, Gonz\u00e1lez-Ferreiro R, Rodr\u00edguez-Gabella T, et al. Recurrence of Device-Related Thrombus After Percutaneous Left Atrial Appendage Closure. Circulation. 2019;140(17):1441\u20133.","journal-title":"Circulation"},{"issue":"8","key":"2865_CR25","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/jce.14053","volume":"30","author":"B Sivasambu","year":"2019","unstructured":"Sivasambu B, Arbab-Zadeh A, Hays A, Calkins H, Berger RD. Delayed endothelialization of watchman device identified with cardiac CT. J Cardiovasc Electrophys. 2019;30(8):1319\u201324.","journal-title":"J Cardiovasc Electrophys"},{"issue":"15","key":"2865_CR26","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jacc.2018.02.023","volume":"71","author":"J Torrado","year":"2018","unstructured":"Torrado J, Buckley L, Dur\u00e1n A, Trujillo P, Toldo S, Valle Raleigh J, Abbate A, Biondi-Zoccai G, Guzm\u00e1n LA. Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis. J Am Coll Cardiol. 2018;71(15):1676\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2865_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330\u201393.","journal-title":"Eur Heart J"},{"issue":"1","key":"2865_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","volume":"53","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, J\u00fcni P, Kastrati A, Kolh P, Mauri L, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J cardio-thoracic surgery: official J Eur Association Cardio-thoracic Surg. 2018;53(1):34\u201378.","journal-title":"Eur J cardio-thoracic surgery: official J Eur Association Cardio-thoracic Surg"},{"issue":"31","key":"2865_CR29","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","volume":"37","author":"LV Boersma","year":"2016","unstructured":"Boersma LV, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, Pokushalov E, Kische S, Schmitz T, Stein KM, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37(31):2465\u201374.","journal-title":"Eur Heart J"},{"issue":"11","key":"2865_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","volume":"12","author":"L S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard L, Wong YH, Reddy VY, Boersma LVA, Bergmann MW, Doshi S, Kar S, Sievert H, Wehrenberg S, Stein K, et al. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. JACC Cardiovasc interventions. 2019;12(11):1055\u201363.","journal-title":"JACC Cardiovasc interventions"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02865-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02865-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02865-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T18:44:27Z","timestamp":1664822667000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02865-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02865-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out according to the principles of the declaration of Helsinki and was approved by the ethics committees of Shanghai Tongji Hospital and East Hospital. Informed consent was signed by all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}